Detail akcie NoVacyt online

Business Summary: Novacyt SA is a France-based company providing biotechnological solutions. The Company develops and markets solutions dedicated to the field of liquid-based cytology and molecular biology. It provides diagnostic products used in oncology, microbiology, haematology, and serology testing. The Company develops secure automated cytology named NovaPrep Processor System. It offers a solution of cytological sampling to help in the detection of precancerous and cancerous lesions. It creates bottles specifically dedicated to the optimization of cell collection. The Company’s range of products includes Bottle Gyn and No Gyn Bottle.
Financial Summary: BRIEF: For the six months ended 30 June 2025, Novacyt SA revenues decreased 5% to L9.8M. Net loss before extraordinary items decreased 62% to L6.8M. Revenues reflect Yourgene Health segment decrease of 3% to L7.6M, America segment decrease of 25% to L1.1M, France segment decrease of 17% to L1.1M. Lower net loss reflects General and administrative expenses decrease of 25% to L8.2M (expense).